Dupilumab Consistently Improves Rhinoconjunctivitis‐Specific Health‐Related Quality of Life in Patients With Uncontrolled, Moderate‐to‐Severe Asthma and Comorbid Allergic Rhinitis: Results from the Phase 3 LIBERTY ASTHMA QUEST Study: 304